Last updated: 15:41
No Notes Added Yet
1. Business Overview
GSM Foils Ltd. is an Indian manufacturer specializing in various types of aluminum foils primarily used for packaging. The company's core business involves the conversion of aluminum foil jumbo rolls into finished packaging foils. Their product portfolio includes blister foils (for pharmaceutical packaging), strip foils, alu-alu laminate foils, and other packaging foils used across pharmaceuticals, food, and other industries. They serve both domestic and international markets. The company makes money by manufacturing and selling these finished aluminum foil products to other businesses (B2B model) that require packaging solutions.
2. Key Segments / Revenue Mix
While specific revenue breakdown by product type or geography isn't always publicly detailed for an SME, GSM Foils primarily operates in a single segment: the manufacturing and supply of various aluminum foils for packaging. Their main product categories include:
Blister Foils: Used for packaging tablets and capsules in the pharmaceutical sector.
Strip Foils: Also for pharmaceutical packaging.
Alu-Alu Laminate Foils: Advanced pharmaceutical packaging.
Other Packaging Foils: Catering to food and other industrial packaging needs.
The pharmaceutical packaging segment is a significant focus for the company.
3. Industry & Positioning
GSM Foils operates within the Indian packaging industry, specifically the flexible packaging and aluminum foil segment. This industry is fragmented with a mix of large integrated players and numerous smaller, specialized manufacturers. The demand is driven by growth in end-user industries like pharmaceuticals, food & beverages, and personal care. GSM Foils positions itself as a specialized manufacturer of pharmaceutical-grade aluminum foils, focusing on quality and compliance, which are critical in the highly regulated pharma sector. They are a smaller player compared to large, diversified packaging conglomerates but aim to compete on product specialization, quality, and customer service.
4. Competitive Advantage (Moat)
GSM Foils operates in a competitive industry, and durable competitive advantages can be challenging for smaller players. Potential advantages might include:
Customer Relationships & Approvals: Especially in pharmaceuticals, getting approvals from drug manufacturers for packaging materials requires stringent quality control and reliability, which can lead to sticky customer relationships once established.
Product Specialization: A focused approach on specific high-quality pharmaceutical foils might give them an edge over generalist manufacturers who may not meet the same compliance standards.
Operational Efficiency: Continuous improvement in manufacturing processes and cost management could offer a competitive edge in pricing or profitability.
However, the company likely does not possess a strong brand moat, significant economies of scale comparable to large players, or proprietary technology that creates high switching costs across the broader market.
5. Growth Drivers
Growing Pharmaceutical Sector: India's pharmaceutical industry is a major consumer of specialized packaging foils. Continued growth in drug production and exports will drive demand for GSM Foils' products.
Expansion in Food & FMCG Packaging: Increasing consumption of packaged food and FMCG products in India provides opportunities for diversification beyond pharma and overall demand growth for aluminum foils.
Capacity Expansion: Any planned increase in manufacturing capacity or backward/forward integration can directly contribute to higher sales volumes.
Export Opportunities: Tapping into global markets, particularly for pharmaceutical packaging, can provide new avenues for growth and reduce dependence on the domestic market.
Product Diversification/Innovation: Introduction of new types of packaging foils or more sustainable solutions could open new market segments.
6. Risks
Raw Material Price Volatility: Aluminum is a key raw material, and its price fluctuations (driven by global commodity markets) can significantly impact manufacturing costs and profit margins.
Intense Competition: The packaging industry, including the foil segment, is competitive, with numerous players vying for market share, which can put pressure on pricing.
Customer Concentration: Reliance on a few large customers for a significant portion of revenue could pose a risk if those relationships are disrupted or orders decrease.
Regulatory Changes: Especially in the pharmaceutical sector, changes in packaging regulations or quality standards could require costly adaptations.
Economic Downturn: A slowdown in the economy can impact end-user industries like pharma and food, leading to reduced demand for packaging materials.
Technological Obsolescence: While less common for basic foils, advancements in alternative packaging materials could pose a long-term threat.
7. Management & Ownership
GSM Foils Ltd. is a promoter-driven company. The key promoters are Mr. Gyaneshwar Singh and Mr. Anil Kumar, who have experience in the packaging industry. As of its IPO, the promoters held a significant stake in the company, reflecting a concentrated ownership structure common in SMEs in India. Management quality can be inferred from their operational track record and adherence to regulatory compliance in a sensitive sector like pharma packaging.
8. Outlook
GSM Foils is positioned in a growing market driven by India's expanding pharmaceutical and food industries. The company's specialization in pharmaceutical-grade foils offers a niche with higher quality requirements and potential for sticky customer relationships. Growth drivers include the robust domestic pharma sector, increasing consumption of packaged goods, and potential for capacity expansion and exports. However, the business faces inherent risks such as volatile raw material prices, intense competition from larger players, and potential customer concentration. The ability to manage input costs effectively, maintain strong customer relationships, and potentially diversify its product and customer base will be crucial for sustained performance in this competitive and commodity-influenced industry.
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Market Cap ₹251 Cr.
Stock P/E 26
P/B 3.7
Current Price ₹195.6
Book Value ₹ 52.8
Face Value 10
52W High ₹255.2
Dividend Yield 0%
52W Low ₹ 130.7
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
| #(Fig in Cr.) | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 14 | 21 | 31 | 36 | 46 | 52 | 58 | 66 | 82 |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income | 14 | 21 | 31 | 36 | 46 | 52 | 58 | 66 | 82 |
| Total Expenditure | 13 | 19 | 28 | 32 | 40 | 46 | 51 | 58 | 72 |
| Operating Profit | 1 | 2 | 3 | 4 | 6 | 6 | 7 | 8 | 10 |
| Interest | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 1 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 0 | 2 | 3 | 4 | 5 | 5 | 6 | 7 | 8 |
| Provision for Tax | 0 | 1 | 1 | 1 | 2 | 2 | 1 | 2 | 2 |
| Profit After Tax | 0 | 1 | 2 | 3 | 3 | 4 | 4 | 5 | 6 |
| Adjustments | 0 | 0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | 0 | 1 | 2 | 3 | 3 | 4 | 4 | 5 | 6 |
| Adjusted Earnings Per Share | 0.3 | 1.1 | 1.7 | 2.1 | 2.7 | 3 | 3.1 | 3.8 | 4.5 |
| #(Fig in Cr.) | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|
| Net Sales | 41 | 134 | 258 |
| Other Income | 0 | 0 | 0 |
| Total Income | 41 | 134 | 258 |
| Total Expenditure | 38 | 119 | 227 |
| Operating Profit | 3 | 15 | 31 |
| Interest | 1 | 1 | 3 |
| Depreciation | 0 | 0 | 0 |
| Exceptional Income / Expenses | 0 | 0 | 0 |
| Profit Before Tax | 2 | 14 | 26 |
| Provision for Tax | 0 | 4 | 7 |
| Profit After Tax | 1 | 10 | 19 |
| Adjustments | 0 | 0 | 0 |
| Profit After Adjustments | 1 | 10 | 19 |
| Adjusted Earnings Per Share | 1.5 | 7.5 | 14.4 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 227% | 0% | 0% | 0% |
| Operating Profit CAGR | 400% | 0% | 0% | 0% |
| PAT CAGR | 900% | 0% | 0% | 0% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | 28% | NA% | NA% | NA% |
| ROE Average | 46% | 29% | 29% | 29% |
| ROCE Average | 46% | 31% | 31% | 31% |
| #(Fig in Cr.) | Mar 2024 | Mar 2025 |
|---|---|---|
| Shareholder's Funds | 11 | 31 |
| Minority's Interest | 0 | 0 |
| Borrowings | 1 | 0 |
| Other Non-Current Liabilities | 0 | 0 |
| Total Current Liabilities | 8 | 30 |
| Total Liabilities | 20 | 61 |
| Fixed Assets | 1 | 2 |
| Other Non-Current Assets | 0 | 3 |
| Total Current Assets | 19 | 56 |
| Total Assets | 20 | 61 |
| #(Fig in Cr.) | Mar 2024 | Mar 2025 |
|---|---|---|
| Opening Cash & Cash Equivalents | 0 | 0 |
| Cash Flow from Operating Activities | -13 | -18 |
| Cash Flow from Investing Activities | -1 | -5 |
| Cash Flow from Financing Activities | 14 | 22 |
| Net Cash Inflow / Outflow | 0 | -0 |
| Closing Cash & Cash Equivalent | 0 | 0 |
| # | Mar 2024 | Mar 2025 |
|---|---|---|
| Earnings Per Share (Rs) | 1.46 | 7.53 |
| CEPS(Rs) | 1.6 | 7.75 |
| DPS(Rs) | 0 | 0 |
| Book NAV/Share(Rs) | 11.77 | 24.39 |
| Core EBITDA Margin(%) | 6.67 | 11.36 |
| EBIT Margin(%) | 6.35 | 11.17 |
| Pre Tax Margin(%) | 4.54 | 10.19 |
| PAT Margin (%) | 3.35 | 7.21 |
| Cash Profit Margin (%) | 3.67 | 7.42 |
| ROA(%) | 6.85 | 23.72 |
| ROE(%) | 12.4 | 45.66 |
| ROCE(%) | 15.75 | 45.62 |
| Receivable days | 64.67 | 55.92 |
| Inventory Days | 91.48 | 39.68 |
| Payable days | 28.96 | 16.29 |
| PER(x) | 0 | 16.01 |
| Price/Book(x) | 0 | 4.95 |
| Dividend Yield(%) | 0 | 0 |
| EV/Net Sales(x) | 0.35 | 1.31 |
| EV/Core EBITDA(x) | 5.29 | 11.49 |
| Net Sales Growth(%) | 0 | 227.67 |
| EBIT Growth(%) | 0 | 476.74 |
| PAT Growth(%) | 0 | 605.53 |
| EPS Growth(%) | 0 | 416.09 |
| Debt/Equity(x) | 0.49 | 0.57 |
| Current Ratio(x) | 2.38 | 1.86 |
| Quick Ratio(x) | 1.11 | 1.23 |
| Interest Cover(x) | 3.51 | 11.36 |
| Total Debt/Mcap(x) | 0 | 0.11 |
| # | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Promoter | 73.14 | 73.14 | 73.14 | 73.14 | 66.49 | 66.54 | 66.54 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0.79 | 1.16 | 1.82 |
| Public | 26.86 | 26.86 | 26.86 | 26.86 | 32.71 | 32.3 | 31.64 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Promoter | 0.94 | 0.94 | 0.94 | 0.94 | 0.94 | 0.94 | 0.94 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0.01 | 0.02 | 0.03 |
| Public | 0.34 | 0.34 | 0.34 | 0.34 | 0.46 | 0.46 | 0.45 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1.28 | 1.28 | 1.28 | 1.28 | 1.41 | 1.41 | 1.41 |
* The pros and cons are machine generated.
You May Also Know About
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.